BRAIN METASTASIS FROM UTERINE MALIGNANCIES: TREATMENT MODALITIES AND PROGNOSTIC FACTORS

February 4, 2017
Written by Super User
Published in Oncology
0 comments

Naoual Benhmidou¹, Fadoua Rais¹, Abdellah Aissa¹, Otman Akkar², Khadija Bellahammou², Hasna Loughlimi¹, Abdelhak Maghous¹, Fadila Kouhen¹, Tayeb Kebdani¹, Hanan Elkacemi¹, Sanaa Elmajjaoui¹, Noureddine Benjaafar¹.

1) Department of Radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Morocco.

2) Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco.

Disclosure: The author has declared no conflicts of interest.

Received: 21.04.16 Accepted: 10.06.16

Citation: 10.5455/ijsm.brain-metastases-uterine

Fulltext PDF Download

Cite/Export: EndNote/RefWorks

Abstract:

Isolated brain metastases from gynecologic malignancies are unusual. Advances in therapeutic modalities including surgery, whole brain radiotherapy stereotactic radiosurgery and chemotherapy improved survival and quality of life in this population. Therapeutic decision is based on patients’ specific prognostic factors. We report three cases of isolated brain metastases from gynecologic cancers and discuss treatment modalities in the light of a literature review.

Keywords: Brain metastasis, gynecologic malignancies, brain surgery, stereotactic radiosurgery, whole brain radiotherapy

How to Cite this Article

Bibliography

Benhmidou, N., Rais, F., Aissa, A., Akkar, O., Bellahammou, K., Loughlimi, H., Maghous, A., Kouhen, F., Kebdani, T., Elkacemi, H., Elmajjaoui, S. and Benjaafar, N. (2017) ‘Brain metastasis from uterine malignancies: Treatment modalities and prognostic factors’, International Journal of Surgery and Medicine, , p. Online First. doi: 10.5455/ijsm.brain-metastases-uterine.